Selective estrogen receptor modulators in coronary artery disease--are they here to stay?
Chandrasekar
B
B
Vijaya Heart Foundation, Vijaya Hospital, Chennai.
D000368:Aged; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage; D018570:Risk Assessment; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D015996:Survival Rate; D013629:Tamoxifen / Q000008:administration & dosage; D016896:Treatment Outcome
D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride